Shosha, Esraa
Shahror, Rami A.
Morris, Carol A.
Xu, Zhimin
Lucas, Rudolf
McGee-Lawrence, Meghan E.
Rusch, Nancy J.
Caldwell, Ruth B. http://orcid.org/0000-0003-0168-0354
Fouda, Abdelrahman Y. http://orcid.org/0000-0003-3042-9425
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (4 R00 EY029373-03)
Article History
Received: 6 June 2023
Revised: 6 September 2023
Accepted: 12 September 2023
First Online: 21 September 2023
Competing interests
: AYF and RBC have a pending patent on the use of arginase 1 as a treatment for ischemic retinopathies. The other authors declare no conflict of interest.
: All experiments were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Institutional Animal Care and Use Committee. Studies were approved by UAMS and AU animal use committees.
: Not applicable.